Life Sciences
Asia-Pacific Guide 2024 : Asia-Pacific Region
Band 2
Email address
[email protected]Contact number
+1 202 879 3939Chambers Review
Jones Day fields a talented group distinguished for the scope of its expertise. It handles a range of M&A for pharmaceutical corporate and start-ups in addition to advising on licensing matters and regulatory compliance. The firm is also proficient in liaising between its offices in dealing with the protection and enforcement of IP assets, especially patents. It is additionally proficient in international arbitration relating to this sector. It leverages its global network to assist clients with international matters and often works in conjunction with US-based teams.
Tony Chen in Shanghai is a key contact for the group.
Work Highlights
- Jones Day advised Incyte on its collaboration and licensing agreement with CMS Aesthetics for the development and commercialisation of ruxolitinib cream, a medicine for the treatment of autoimmune and inflammatory dermatological diseases.
- Jones Day advised Kaken Pharmaceutical with respect to a collaboration agreement with CymaBay Therapeutics for the development and commercialisation of Seladelpar in Japan.
Strengths
Provided by Chambers
"If we feel expertise is needed, Jones Day can find the suitable lawyers."
"The firm makes complex issues easy to understand. The team's advice is straightforward and logical, and they are always client-friendly."
"If we feel expertise is needed, Jones Day can find the suitable lawyers."
"The firm makes complex issues easy to understand. The team's advice is straightforward and logical, and they are always client-friendly."